Showing results (1071-1080 of 1,133) with videos related to
Sort By:
Pageof 114
Cancers|January 21, 2023
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome AnalysisMelissa M De Meza, Willeke A M Blokx, Johannes J Bonenkamp, et al.Cancers|July 31, 2020
Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and ResponseMonique K van der Kooij, Marjolein J A L Wetzels, Maureen J B Aarts, et al.Diagnostics (Basel, Switzerland)|February 24, 2024
Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast CancerJorianne Boers, Bertha Eisses, Mieke C Zwager, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2020
Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment RegistryRik J Verheijden, Anne M May, Christian U Blank, et al.Melanoma Research|June 15, 2022
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitorsRawa K Ismail, Karijn P M Suijkerbuijk, Anthonius de Boer, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 21, 2021
Nationwide oncological networks for resection of colorectal liver metastases in the Netherlands: Differences and postoperative outcomesArthur K E Elfrink, Niels F M Kok, Rutger-Jan Swijnenburg, et al.Cancers|July 2, 2021
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint InhibitorsNienke A de Glas, Esther Bastiaannet, Frederiek van den Bos, et al.Circulation|May 5, 2016
Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D Gillmore, Mathew S Maurer, Rodney H Falk, et al.European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registryM C T van Zeijl, L C de Wreede, A J M van den Eertwegh, et al.International Journal of Cancer|June 26, 2024
Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide studyManja Bloem, Olivier J van Not, Maureen J B Aarts, et al.Pageof 114